The Incidental Economist is writing about a House Bill to remove AHRQ as an agency and to remove economic research from the National Institutes of Health.
I am of decidedly mixed feelings. I can definitely see how the focus in the
NIH should be on the science. Single, focused mandates can improve the ability
of an agency to perform a critical task.
But that, if anything, is why AHRQ is critical. If we want to remove
economic research from the NIH (to improve focus and metrics) then it would
make a second agency, with the appropriate mandate, even more important. This
is very similar to the FDA, which focuses on safety, needing a partner organization
that is considering cost.
So that rather inclines me towards the view that I like the improved NIH
focus but see pairing it with the elimination of AHRQ as being a very
NOTE: the preceding was entirely personal opinion. It does not represent any
institution that I have been affiliated with or will be affiliated with. I have
received funding from AHRQ.
INET Hong Kong: The RMB and the Future of Asian Finance
46 minutes ago